This is a limited company view. Sign up for a Free Trial to see everything.

Medisyn Technologies develops pre-qualified proprietary drug compounds for breast, renal, prostate, and lung cancer treatments.

B2B
Biotechnology
Cleantech
E-Commerce
Healthcare
Pharmaceuticals
Wind Power

Overview

Location

Minneapolis

Founded

1999

Employees

1

Stage

Late

Total funding

$2M

Last funding

13 years ago

Acquisitions

0

Growth score

0

Mindshare score

0

Scoring

Employee Growth

Use Medisyn Technologies's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Medisyn Technologies's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Director, Technical Program

Similar Companies

Promentis Pharmaceuticals

Promentis is a biopharmaceutical company focused on the discovery and development of first-in-class therapies to treat central nervous system (CNS) disorders.
Series C|6 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes